secwatch / observer
8-K filed March 4, 2025, 6:59 PM ET ticker MET CIK 0001099219
debt confidence high sentiment neutral materiality 0.55

METLIFE INC (MET): debt financing — MetLife establishes $1.25B P-Caps facility with 5.740% Senior Notes due 2055

METLIFE INC

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

METLIFE INC incurred senior notes of $1,250,000,000 with 200 Park Funding Trust and The Bank of New York Mellon Trust Company, N.A. at 5.740% maturing February 15, 2055.

Instrument
senior notes
Principal
$1,250,000,000
Counterparty
200 Park Funding Trust and The Bank of New York Mellon Trust Company, N.A.
Rate
5.740%
Maturity
February 15, 2055
Event
incurrence
Exact text from the filing
On March 4, 2025 (the “Closing Date”), pursuant to the Purchase Agreement among MetLife, Inc. (the “Company”), 200 Park Funding Trust, a Delaware statutory trust (the “Trust”), and TD Securities (USA) LLC, Barclays Capital Inc., BofA Securities, Inc., Goldman Sachs & Co. LLC and Wells Fargo Securities, LLC, as representatives of the several initial purchasers, the Trust completed the issuance and sale of 1,250,000 of its Pre-Capitalized Trust Securities redeemable February 15, 2055 (the “P-Caps”) for an aggregate purchase price of $1,250,000,000 in private placements pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), as a contingent funding arrangement that provides the Company the right at any time over a thirty-year period to issue its 5.740% Senior Notes due 2055 (the “Senior Notes”) to the Trust, at its election, as described below.
View on SEC.gov

10 debt financings filed in the last 30 days. Browse all debt financings →

METLIFE INC filing history →

Source: SEC EDGAR
accession 0001193125-25-045644
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.